NCT00828633

Brief Summary

RATIONALE: Gathering information about prostate cancer, treatment, and quality of life from gay men with prostate cancer may help doctors plan the best treatment. PURPOSE: This clinical trial is collecting information about health-related quality of life from gay men with localized prostate cancer.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
92

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2008

Longer than P75 for all trials

Geographic Reach
2 countries

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2008

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

January 23, 2009

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 26, 2009

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2010

Completed
4.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2015

Completed
Last Updated

January 23, 2018

Status Verified

January 1, 2018

Enrollment Period

2.3 years

First QC Date

January 23, 2009

Last Update Submit

January 18, 2018

Conditions

Keywords

stage I prostate cancerstage II prostate cancer

Outcome Measures

Primary Outcomes (3)

  • Effect of disease factors and treatment factors on subjective well-being

    Cross-sectional retrospective study, one timepoint

  • Effect of disease factors and treatment factors on illness intrusiveness

    Cross-sectional retrospective study, one timepoint

  • Effect of psychosocial factors on subjective well-being

    Cross-sectional retrospective study, one timepoint

Eligibility Criteria

Age18 Years - 100 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Convenience sample contacted via Internet

DISEASE CHARACTERISTICS: * Diagnosis of localized prostate cancer * No advanced disease * Self-identified as gay PATIENT CHARACTERISTICS: * Able to complete an online questionnaire * Able to speak and understand English PRIOR CONCURRENT THERAPY: * Not specified

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (3)

Dan L. Duncan Cancer Center at Baylor College of Medicine

Houston, Texas, 77030, United States

Location

Veterans Affairs Medical Center - Houston

Houston, Texas, 77030, United States

Location

Ryerson University

Toronto, Ontario, M5B 2K3, Canada

Location

MeSH Terms

Conditions

Prostatic Neoplasms

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital Diseases

Study Officials

  • David M. Latini, PhD

    Baylor College of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Adjunct Assistant Professor of Urology

Study Record Dates

First Submitted

January 23, 2009

First Posted

January 26, 2009

Study Start

August 1, 2008

Primary Completion

December 1, 2010

Study Completion

June 1, 2015

Last Updated

January 23, 2018

Record last verified: 2018-01

Locations